IL10 and neoplasm: Meanwhile, IL-10 prevalence within the TME compromises the functionality of dendritic cells (DCs) and safeguards tumor cells from cytotoxic T lymphocyte (CTL)-mediated cytotoxicity by downregulating TAP1 and TAP2 [60, 61].